| Market Cap | ₹7.16Cr |
| ROE | 3.00% |
| P/E Ratio(TTM) | -42.00 |
| EPS(TTM) | -0.05 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 46.04 |
| Book Value | -1.54 |
| Debt to Equity | -0.34 |
| Face Value | 5 |
| Managing Director | Mr. Mukesh Naik |
| BSE Symbol | 524764 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 67.38 | ||
| Acutaas Chemicals | NA (0.00%) | 59.10 | ||
| Neuland Laboratories | NA (0.00%) | 90.63 | ||
| Jubilant Pharmova | NA (0.00%) | 32.22 |